.jpg)
.png)
All
A healthy diet is a powerful tool for the prevention and management of cardiovascular disease (CVD).1 Despite low-fat recommendations, the prevalence of obesity continues to increase steadily,2 because fat intake has not decreased in the United States.3 Accompanying this rise is the... more
The primary health care of women is a complex world of "Hearts, Hormones, Ovaries, Breasts and Bones." Over the past year women have expressed concern when reading articles and listening to media reports that suggest taking calcium supplements may help prevent fractures but at the same... more
Lipoproteins, Lipids, Cognitive Impairment and Vascular Disease Lipid Luminations
Recent clinical trial data has strengthened the argument that lowering low-density lipoprotein cholesterol (LDL-C) to levels well below those previously targeted provides incremental benefit in terms of lowering the risk of atherosclerotic cardiovascular disease (ASCVD).1 The increased use of high-... more
“An ounce of prevention is worth a pound of cure.” — Benjamin Franklin Introduction Truisms carry no scientific weight, but that doesn’t mean they can’t be true. For decades now, primary prevention has been based on the cardiovascular risk model. This approach, which appears simply to be... more
This issue sponsored by the Pacific Lipid Association Featuring: "HDL-P vs. ApoA1 vs. HDL-C" in Context of the HDL-Hypothesis Controversy The Role of Remnant Lipoproteins in Atherogenesis
Complex Lipid Management Self-Assessment Programs & NLA Self-Study Modules The Complex Lipid Management-Self-Assessment Program (CLM-SAP) and the NLA Self-Study Modules (NLA-SSM) provide problem-solving case-based questions that involve common pharmacological issues faced by lipid... more
The National Lipid Association (NLA) was surveyed this year by the Accreditation Council for Continuing Medical Education (ACCME) and awarded Accreditation with Commendation for the next six years as a provider of continuing medical education for physicians. The NLA’s new accreditation term expires... more
This issue sponsored by the Pacific Lipid Association Featuring: "PCSK9 Monoclonal Antibody Therapy – The Latest Data and Who is Appropriate for Treatment" and "Tuberous and Tendon Xanthomas: Don’t Overlook Sitosterolemia or Cerebrotendinous Xanthomatosis" more
2014 NLA Honors & Awards To honor the exceptional professionals in our ranks, the NLA has established several types of recognition. We are currently seeking nominations for the following awards, to be presented at the 2014 Annual Scientific Sessions in Orlando, Florida (May 1-4, 2014):... more